To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Role of erythropoietin in reducing allogeneic transfusions after joint arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2014

Role of erythropoietin in reducing allogeneic transfusions after joint arthroplasty

Vol: 3| Issue: 9| Number:57| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Preoperative Use of Recombinant Human Erythropoietin Before Total Joint Arthroplasty

J Bone Joint Surg Am. 2003 Sep;85-A(9):1795-800

Contributing Authors:
HP Bezwada DG Nazarian DH Henry Booth RE

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

240 patients undergoing arthroplasty of the hip or knee were randomized to preoperatively receive erythropoietin and autologous donation (Group 1), erythropoietin alone (Group 2), or preoperative autologous donation alone (Group 3). Patients were then evaluated postoperatively for allogeneic transfusion requirements, hemoglobin values, and complications or adverse reactions. Patients in Group 1 ha...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.

Continue